Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bethany J Cavanagh Insider Profile
4 Followers
Bethany J Cavanagh, SVP, Finance and Treasurer at Beam Therapeutics, holds 43.81K shares in Beam Therapeutics (Ticker: BEAM).
Bethany J Cavanagh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bethany J Cavanagh's holdings
Insider Roles
SVP, Finance and Treasurer
Roles that Bethany J Cavanagh holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Bethany J Cavanagh
Bethany J Cavanagh's Trading History
List of latest transactions for each holding click on a transaction to see Bethany J Cavanagh's performance on stock
You May Also Like
Bethany J Cavanagh insider profile FAQ
What is the percentage of profitable transactions made by Bethany J Cavanagh?
The percentage of profitable transactions made by Bethany J Cavanagh is ―.
What is the average return per transaction made by Bethany J Cavanagh?
The average return per transaction made by Bethany J Cavanagh is ―.
What stocks does Bethany J Cavanagh hold?
Bethany J Cavanagh holds: BEAM stocks.
What was Bethany J Cavanagh’s latest transaction?
Bethany J Cavanagh latest transaction was an Uninformative Sell of $27.57K.
What was Bethany J Cavanagh's most profitable transaction?
Bethany J Cavanagh’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Bethany J Cavanagh's role in Beam Therapeutics?
Bethany J Cavanagh's role in Beam Therapeutics is SVP, Finance and Treasurer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.